Investcorp takes stakes in China healthcare companies

The $32 billion multi-strategy alternative investment firm Investcorp announced the launch of a new platform dedicated to investment in Chinese healthcare companies. The new platform advances the firm’s Asia growth strategy, officials said in a press release. The aim is to create a "curated" portfolio of primary and secondary stakes in ‘sector leading’ Chinese healthcare companies that have remained resilient through the pandemic and are expected to experience accelerated growth in the post-pandemic world. So far Investcorp has already acquired minority equity stakes in Lu Daopei Medical Group and WeDoctor. The terms of those transactions have not been disclosed. "The progress we have delivered on our expansion in Asia over the last two years, including establishing a world-class team and building our local expertise, has enabled us to take this significant next step in launching our first stand-alone investment platform in China," said Mohammed Alardhi, executive chairman of Investcorp. "We believe that there are many attractive opportunities in the Chinese healthcare sector as this is a pivotal time to meet increasing demand for quality medical services and treatments." Lu Daopei Medical Group was founded in 2001 by Dr. Lu Daopei and has become a leading private specialist medical group in the field of hematology in China and a pioneer of bone marrow transplantation. The company has four hospitals across Beijing and Shanghai and is now the largest bone marrow transplant group for leukemia in the world. Meanwhile, WeDoctor is an online company founded in 2010 by artificial intelligence expert Jerry Liao. The company builds, owns and operates one of China’s largest digital healthcare infrastructure platforms by linking hospitals and doctors with patients, pharmacies, insurance programs and financial services.

Continue Reading With a Free Trial

Be an Alts Watcher

Subscribe to our mailing list and know first!

New finance fund offers unique access to lending strategies

Ex-CDPQ exec joins London infrastructure firm

Related Articles

Artificial intelligence makes winning moves in asset management

Bitcoin buzz lures hedge funds

TIG buys stake in HK credit firm Arkkan

AW Investor Scorecard: Allocators finalize $14bn plus in private market commitments

Get our daily news digest in your inbox

Get our daily news digest
in your inbox